T 0654/21 (Liquid adalimumab composition / FRESENIUS) of 09.06.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T065421.20220609
- Date of decision
- 9 June 2022
- Case number
- T 0654/21
- Petition for review of
- -
- Application number
- 15724974.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- LIQUID PHARMACEUTICAL COMPOSITION
- Applicant name
- Fresenius Kabi Deutschland GmbH
- Opponent name
- Biogen Inc.
Samsung Bioepis UK Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)
- Keywords
- Grounds for opposition - added subject-matter (yes)
Grounds for opposition - combination of selected features
Amendments - allowable (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.